ARTICLE | Clinical News
HTX-011: Ph II Study 203 data
February 16, 2017 8:13 PM UTC
Top-line data from the double-blind, U.S. Phase II Study 203 in about 200 patients undergoing an abdominoplasty showed that a single dose of HTX-011 significantly reduced SPI score over 96 hours post-...
BCIQ Company Profiles